Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6705363, 9 pages
https://doi.org/10.1155/2017/6705363
Review Article

The Effect of Granulocyte Colony-Stimulating Factor on the Progression of Atherosclerosis in Animal Models: A Meta-Analysis

1Department of Pathology and Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi, Xinjiang, China
2Department of Pathology, The First Affiliated Hospital to Shihezi University School of Medicine, Shihezi, Xinjiang, China
3Department of Cardiology, The First Affiliated Hospital to Shihezi University School of Medicine, 45 North 3rd Road, Shihezi, Xinjiang, China
4Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, China
5Department of Orthopaedics, Shihezi University School of Medicine, 45 North 3rd Road, Shihezi, Xinjiang, China

Correspondence should be addressed to Weishan Wang; moc.361@77623997631m and Lijuan Pang; moc.361@654321naeco

Received 1 January 2017; Accepted 12 July 2017; Published 12 September 2017

Academic Editor: Louise Bennett

Copyright © 2017 Manli Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. K. Hansson, “Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1626–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Ross and B. Dodet, “Atherosclerosis is an inflammatory disease,” American Heart Journal, vol. 138, no. 5, part 2, pp. S419–S420, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G.-H. Fong, “Potential contributions of intimal and plaque hypoxia to atherosclerosis,” Current atherosclerosis reports, vol. 17, no. 6, p. 510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Lusis, “Atherosclerosis,” Nature, vol. 407, no. 6801, pp. 233–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Greenbaum and D. C. Link, “Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization,” Leukemia, vol. 25, no. 2, pp. 211–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Tanaka, T. Miyake, T. Shimizu et al., “Effect of Continuous Subcutaneous Administration of a Low Dose of G-CSF on Stem Cell Mobilization in Healthy Donors: A Feasibility Study,” International Journal of Hematology, vol. 75, no. 5, pp. 489–492, 2002. View at Publisher · View at Google Scholar
  7. F. Bussolino, M. Ziche, J. Ming Wang et al., “In vitro and in vivo activation of endothelial cells by colony-stimulating factors,” The Journal of Clinical Investigation, vol. 87, no. 3, pp. 986–995, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Deotare, G. Al-Dawsari, S. Couban, and J. H. Lipton, “G-CSF-primed bone marrow as a source of stem cells for allografting: Revisiting the concept,” Bone Marrow Transplantation, vol. 50, no. 9, pp. 1150–1156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Zhang, Y. Wu, A. Chen, and Q. Zhao, “Mesenchymal stem cells promote cardiac muscle repair via enhanced neovascularization,” Cellular Physiology and Biochemistry, vol. 35, no. 3, pp. 1219–1229, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Yin, H. Liu, F. Wang et al., “Transplantation of cryopreserved human umbilical cord blood-derived endothelial progenitor cells induces recovery of carotid artery injury in nude rats,” Stem Cell Research and Therapy, vol. 6, no. 1, article 37, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. X. Wang, C. Q. Wang, X. Y. Li et al., “Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4+CD25+FOXP3+ regulatory T-cells and inhibiting macrophage foam cell formation,” Molecular and Cellular Biochemistry, vol. 400, no. 1-2, pp. 163–172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Yao, J. Heuser-Baker, O. Herlea-Pana et al., “Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering,” Stem Cells, vol. 30, no. 12, pp. 2720–2731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Z.-L. Ma, X.-L. Mai, J.-H. Sun et al., “Inhibited atherosclerotic plaque formation by local administration of magnetically labeled endothelial progenitor cells (EPCs) in a rabbit model,” Atherosclerosis, vol. 205, no. 1, pp. 80–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. SZ. Guo, NF. Wang, and L. Zhou, “Influence of granulocyte colony-stimulating factor on cardiac function in patients with acute myocardial infarction and leukopenia after revascularization,” ChinMedJ (Engl, vol. 123, no. 14, 1827. View at Google Scholar
  15. S. Pasquet, H. Sovalat, P. Hnon et al., “Long-term benefit of intracardiac delivery of autologous granulocytecolony-stimulating factor-mobilized blood CD341 cells containing cardiac progenitors on regional heart structure and function after myocardial infarct,” Cytotherapy, vol. 11, no. 8, pp. 1002–1015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Arai, Y. Misao, H. Nagai et al., “Granulocyte colony-stimulating factor - A noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease,” Circulation Journal, vol. 70, no. 9, pp. 1093–1098, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Eyles, A. W. Roberts, D. Metcalf, and I. P. Wicks, “Granulocyte colony-stimulating factor and neutrophils—forgotten mediators of inflammatory disease,” Nature Clinical Practice Rheumatology, vol. 2, no. 9, pp. 500–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Baetta and A. Corsini, “Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives,” Atherosclerosis, vol. 210, no. 1, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Hasegawa, H. Takano, M. Ohtsuka et al., “G-CSF prevents the progression of atherosclerosis and neointimal formation in rabbits,” Biochemical and Biophysical Research Communications, vol. 344, no. 1, pp. 370–376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Matsumoto, H. Watanabe, T. Ueno et al., “Appropriate doses of granulocyte-colony stimulating factor reduced atherosclerotic plaque formation and increased plaque stability in cholesterol-fed rabbits,” Journal of Atherosclerosis and Thrombosis, vol. 17, no. 1, pp. 84–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. SK. Sinha, V. Mishra, S. Nagwani, and TB. Rajavashisth, “Effects of G-CSF on serum cholesterol and development of atherosclerotic plaque in apolipoprotein E-deficient mice,” Int J Clin Exp Med, vol. 7, no. 8, 1979. View at Google Scholar
  22. M. Ditiatkovski, B. Toh, and A. Bobik, “Mo-W12:3 Absence of granulocyte macrophage-colony stimulating factor accelerates development of atherosclerosis in apolipoprotein E-deficient mice,” Atherosclerosis Supplements, vol. 7, no. 3, p. 33, 2006. View at Publisher · View at Google Scholar
  23. D. Tousoulis, A. Briasoulis, G. Vogiatzi et al., “Effects of direct infusion of bone marrow-derived progenitor cells and indirect mobilization of hematopoietic progenitor cells on atherosclerotic plaque and inflammatory process in atherosclerosis,” International Journal of Cardiology, vol. 168, no. 5, pp. 4769–4774, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-Y. Zhao, C.-S. Xiao, L. Qiu, and G.-L. Wang, “Effects of granulocyte colony-stimulating factor on peripheral endothelial progenitor cells in cholesterol-fed rabbits,” Zhonghua xin xue guan bing za zhi [Chinese journal of cardiovascular diseases], vol. 34, no. 3, pp. 257–261, 2006. View at Google Scholar · View at Scopus
  25. A. Haghighat, D. Weiss, M. K. Whalin, D. P. Cowan, and W. R. Taylor, “Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice,” Circulation, vol. 115, no. 15, pp. 2049–2054, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. I. G. van der Spoel, S. J. Jansen Of Lorkeers, P. Agostoni et al., “Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease,” Cardiovascular Research, vol. 91, no. 4, pp. 649–658, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Hartung, “Anti-inflammatory effects of granulocyte colony-stimulating factor,” Current Opinion in Hematology, vol. 5, no. 3, pp. 221–225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. G. J. Elfenbein, “Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: Which to choose?” Pediatric Transplantation, vol. 9, no. 7, pp. 37–47, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Abdel-Latif, R. Bolli, E. K. Zuba-Surma, I. M. Tleyjeh, C. A. Hornung, and B. Dawn, “Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials,” American Heart Journal, vol. 156, no. 2, pp. 216–e9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Vlodaver, R. F. Wilson, and D. J. Garry, Coronary Heart Disease, Springer US, Boston, MA, 2012. View at Publisher · View at Google Scholar
  31. L. Fan, L. Chen, X. Chen, and F. Fu, “A meta-analysis of stem cell mobilization by granulocyte colony-stimulating factor in the treatment of acute myocardial infarction,” Cardiovascular Drugs and Therapy, vol. 22, no. 1, pp. 45–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Ince, M. Valgimigli, M. Petzsch et al., “Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: Systematic review and meta-analysis,” Heart, vol. 94, no. 5, pp. 610–616, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Kang, Y. Yang, C.-J. Li, and R. Gao, “Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: A meta-analysis of randomized controlled trials,” Clinical Therapeutics, vol. 29, no. 11, pp. 2406–2418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Moazzami, A. Roohi, and B. Moazzami, “Granulocyte colony stimulating factor therapy for acute myocardial infarction.,” The Cochrane database of systematic reviews, vol. 5, p. CD008844, 2013. View at Google Scholar · View at Scopus
  35. D. Zohlnhöfer, A. Dibra, T. Koppara et al., “Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction. A Meta-Analysis,” Journal of the American College of Cardiology, vol. 51, no. 15, pp. 1429–1437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. F. M. Rauscher, P. J. Goldschmidt-Clermont, B. H. Davis et al., “Aging, progenitor cell exhaustion, and atherosclerosis,” Circulation, vol. 108, no. 4, pp. 457–463, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. I. P. Touw and G.-J. M. Van De Geijn, “Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders,” Frontiers in Bioscience, vol. 12, no. 3, pp. 800–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. A. W. Roberts, “G-CSF: a key regulator of neutrophil production, but that's not all!,” Growth Factors, vol. 23, no. 1, pp. 33–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Baumann, S. Yousefi, D. Simon, S. Russmann, C. Mueller, and H.-U. Simon, “Functional expression of CD134 by neutrophils,” European Journal of Immunology, vol. 34, no. 8, pp. 2268–2275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Chakraborty, E. R. Hentzen, S. M. Seo, and C. W. Smith, “Granulocyte colony-stimulating factor promotes adhesion of neutrophils,” AJP: Cell Physiology, vol. 284, no. 1, pp. C103–C110, 2003. View at Publisher · View at Google Scholar
  41. K. Kaushansky, “Lineage-specific hematopoietic growth factors,” The New England Journal of Medicine, vol. 354, no. 19, pp. 2034–2045, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Drechsler, R. T. A. Megens, M. Van Zandvoort, C. Weber, and O. Soehnlein, “Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis,” Circulation, vol. 122, no. 18, pp. 1837–1845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Leclercq, X. Houard, M. Philippe et al., “Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment,” Journal of Leukocyte Biology, vol. 82, no. 6, pp. 1420–1429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. M. G. Ionita, P. Van Den Borne, L. M. Catanzariti et al., “High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1842–1848, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Hartwig, C. Silvestre Roig, M. Daemen, E. Lutgens, and O. Soehnlein, “Neutrophils in atherosclerosis: A brief overview,” Hamostaseologie, vol. 35, no. 2, pp. 121–127, 2015. View at Google Scholar · View at Scopus
  46. A. Seneviratne, M. Hulsmans, P. Holvoet, and C. Monaco, “Biomechanical factors and macrophages in plaque stability,” Cardiovascular Research, vol. 99, no. 2, pp. 284–293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. J. L. Johnson, N. P. Jenkins, and W. C. Huang, “Relationship of MMP-14 and TIMP-3 expression with macrophage activation and human atherosclerotic plaque vulnerability,” Mediators of Inflammation, vol. 2014, Article ID 276457, 17 pages, 2014. View at Publisher · View at Google Scholar
  48. N. Sprigg, P. M. Bath, L. Zhao et al., “Granulocyte-colony - Stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: The Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092),” Stroke, vol. 37, no. 12, pp. 2979–2983, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Minnerup, J. Heidrich, J. Wellmann, A. Rogalewski, A. Schneider, and W.-R. Schabitz, “Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia,” Stroke, vol. 39, no. 6, pp. 1855–1861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. W.-R. Schäbitz and A. Schneider, “New targets for established proteins: exploring G-CSF for the treatment of stroke,” Trends in Pharmacological Sciences, vol. 28, no. 4, pp. 157–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Pound, S. Ebrahim, P. Sandercock, M. B. Bracken, and I. Roberts, “Where is the evidence that animal research benefits humans?” British Medical Journal, vol. 328, no. 7438, pp. 514–517, 2004. View at Publisher · View at Google Scholar · View at Scopus